8 insiders have filed at CRSP since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| George Simeon | Director | 2.04M | 2.123% | 3 buys $51.5M | |
| Kulkarni Samarth | Chief Executive Officer | 255.5k | 0.266% | 33 sells $27.4M | |
| Kasinger James R. | General Counsel And Secretary | 94.3k | 0.098% | 14 sells $2.1M | |
| Treco Douglas A | Director | 22.0k | 0.023% | 1 buys $1.1M | |
| Bruno Julianne | Chief Operating Officer | 17.6k | 0.018% | 5 sells $336k | |
| Prasad Raju | Chief Financial Officer | 15.6k | 0.016% | 13 sells $5.6M | |
| Patel Naimish | Chief Medical Officer | 13.1k | 0.014% | 1 buys $50k | 2 sells $293k |
| Greene John | Director | 7.0k | <0.01% | 1 buys $314k |
Full register at boothcheck.com/insiders/CRSP. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.